发明名称 |
FGF-21 mutants comprising polyethylene glycol and uses thereof |
摘要 |
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides comprising extended in vivos half-lives, pharmaceutical compositions comprising FGF21 mutant polypeptides having extended in vivos half lives, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions. |
申请公布号 |
US9279013(B2) |
申请公布日期 |
2016.03.08 |
申请号 |
US200913123205 |
申请日期 |
2009.10.08 |
申请人 |
Amgen Inc. |
发明人 |
Walker Kenneth W.;Gegg, Jr. Colin V.;Hecht Randy I.;Belouski Edward J.;Li Yue-Sheng;Michaels Mark L.;Xu Jing;Ellison Murielle M. |
分类号 |
A61K38/18;C07K14/50;A61K38/00 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide of SEQ ID NO: 4 having a lysine residue substitution at position 36 and at least one amino acid substitution that is: an arginine residue substitution at position 56, 59, 69, or 122; and wherein the isolated polypeptide comprises no more than five amino acid substitutions. |
地址 |
Thousand Oaks CA US |